ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2703Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in CareDx by 22,860 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 3.41% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 41,701 shares, the number of shares held decreased 1.36% compared to the previous period and now represents 2.35% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 81,488 shares, the number of shares held increased 4.2% compared to the previous period and now represents 3.04% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 477 shares, the number of shares held decreased 1.1% compared to the previous period and now represents 1.22% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 23,823 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 5.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 432 shares, the number of shares held decreased 1.09% compared to the previous period and now represents 0.75% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 117,702 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.72% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 279 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 0.97% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 36,468 shares, the number of shares held decreased 7.64% compared to the previous period and now represents 3% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 53,604 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.5% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 1,458 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 17,118 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 2.39% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 35,478 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 4,060 shares, the number of shares held decreased 0.035% compared to the previous period and now represents 4.51% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 59,215 shares, the number of shares held decreased 2.76% compared to the previous period and now represents 3.01% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,989 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 2.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 11,799 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 3.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 2,664 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 4.66% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 7,497 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 5.66% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 35,271 shares, the number of shares held decreased 1.11% compared to the previous period and now represents 4.38% of the total position.
Go to Tiger App to see more news